Innovative drug concept stocks are actively trading again, as both Chengdu Techcent and Chengda Pharmaceuticals surge more than 10%.

Chengdu First Lead and Chengda Pharmaceutical both rose more than 10%, while Baiote, Saisheng Pharmaceuticals, Lizhu Group, Hait Biological, Chenxin Pharmaceuticals, and Health Element and other stocks rose more than 5%.